InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
6
T+90 hit rate
50%
T+90 mean return
+6.3%
Across 26 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Walker Neal, Chairman & CEO. Officer active across 2 companies, notably Aclaris Therapeutics, Inc.. Cumulatively, 34 reports have been logged. Split: 0 buy · 6 sells. Total volume traded: €2m. Activity tracked since 9 February 2022. The latest transaction was filed on 1 February 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations34 total
9,467 sharesCommon StockSEC:0001415889-25-011955:0
9,467 sharesCommon StockSEC:0001415889-25-009937:0
9,466 sharesCommon StockSEC:0001415889-25-006496:0
9,467 sharesCommon StockSEC:0001415889-25-002941:0
3,559 shares@ US$2.480.4% of flowCommon StockSEC:0001415889-25-002941:1
9,467 sharesCommon StockSEC:0001415889-25-000621:0
118,840 shares@ US$1.527.8% of flowCommon StockSEC:0001415889-24-028466:0
9,466 sharesCommon StockSEC:0001415889-24-028074:0
2,721 shares@ US$4.070.5% of flowCommon StockSEC:0001415889-24-028074:1
2,721 shares@ US$2.090.2% of flowCommon StockSEC:0001415889-24-026138:1
9,467 sharesCommon StockSEC:0001415889-24-026138:0
9,467 sharesCommon StockSEC:0001415889-24-024608:0
9,466 sharesCommon StockSEC:0001415889-24-022794:0
43,548 shares@ US$0.721.3% of flowCommon StockSEC:0001415889-24-021154:0
9,467 sharesCommon StockSEC:0001415889-24-020740:0
9,467 sharesCommon StockSEC:0001415889-24-019172:0
9,466 sharesCommon StockSEC:0001415889-24-015371:0
2,722 shares@ US$1.030.1% of flowCommon StockSEC:0001415889-24-015371:1
9,467 sharesCommon StockSEC:0001415889-24-012167:0
9,467 sharesCommon StockSEC:0001415889-24-010060:0
9,466 sharesCommon StockSEC:0001209191-24-004407:0
9,604 shares@ US$0.552100.0% of flowCommon StockSEC:0000950170-23-044379:0
96,150 sharesCommon StockSEC:0001209191-23-016074:0
25,000 shares@ US$16.74717.6% of flowCommon StockSEC:0001209191-23-007032:0
23,382 shares@ US$15.185515.2% of flowCommon StockSEC:0001209191-23-001329:0
25 of 34 declarations
About Walker Neal
Neal Walker is the Chairman and CEO of Aclaris Therapeutics, Inc. He leads the company by defining the strategic vision and overseeing all operations. His role includes managing human resources, business development, and communication with shareholders. Through his leadership, he ensures that the company remains competitive in the market and meets the needs of its clients while achieving its financial objectives.
